But overall use remains low, and security is the major concern.
Only some people have gut microbes capable of digesting nori, the seaweed that wraps sushi.
In a surprise ruling, Myriad's controversial patents on breast and ovarian cancer susceptibility genes are struck down.
Could mimicking the process in humans rejuvenate damaged hearts?
Doubts grow over resveratrol and other compounds under development at the GSK company.
An interesting proof of principle that's unlikely to be put into practice.
The types of genetic factors identified in direct to consumer genetic tests probably won't help most women.
The ADHD drug improves attention by enhancing neural plasticity.
In a pilot project, technology reduced doctor's visits for patients with chronic illness, but will this work on a broader scale?
The company showed off its behemoth instrument at a conference in Florida this week.